PIII Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
386.4M
-0.0%
386.4M
+0.4%
384.8M
+11.5%
345.3M
-3.0%
355.8M
Cost of Revenue
300.4M
-10.6%
336.0M
-21.1%
426.1M
+15.2%
369.8M
+5.2%
351.4M
Gross Profit
86.0M
+70.8%
50.4M
+222.1%
-41244000
-68.1%
-24536000
-652.9%
4.4M
Operating Expenses
44.8M
+6.3%
42.1M
-62.6%
112.6M
+472.1%
19.7M
-48.9%
38.6M
R&D
0
0
0
0
0
SG&A
32.4M
+25.7%
25.8M
-28.8%
36.2M
+61.7%
22.4M
-4.5%
23.4M
Operating Income
41.2M
+400.5%
8.2M
+105.4%
-153866000
-247.9%
-44223000
-29.6%
-34124000
EBITDA
62.3M
+112.4%
29.3M
+122.1%
-132871000
-473.0%
-23190000
-77.8%
-13041000
Net Income
15.7M
+414.8%
3.0M
+101.8%
-165714000
-138.6%
-69461000
-59.1%
-43665000
EPS (Basic)
$-0.63
-270.3%
$0.37
+101.6%
$-23.02
-138.1%
$-9.67
-55.2%
$-6.23
EPS (Diluted)
$-0.63
-296.9%
$0.32
+101.4%
$-23.02
-138.1%
$-9.67
-55.2%
$-6.23
Shares (Diluted)
3.4M
-60.1%
8.4M
+156.5%
3.3M
+0.4%
3.3M
+0.0%
3.3M
P3 Health Partners (PIII) โ€” Financials